Ingrida Ozols, MD
Dermatopathology · Indianapolis, INNPI 1710068796
Payments from drug & device makers
Across 672 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- Sun Pharmaceutical Industries Inc.$1K
- Lilly USA, LLC$1K
- Amgen$852
- Incyte Corporation$843
- plus $6K from 29 others
What the payments were for
- Food & beverage$12,850100%
- Education$600%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 92 | $1,948 |
| Johnson & Johnson | 90 | $1,471 |
| Sun Pharmaceutical Industries Inc. | 67 | $1,187 |
| Lilly USA, LLC | 59 | $1,095 |
| Amgen | 32 | $852 |
| Incyte Corporation | 36 | $843 |
| Novartis | 64 | $810 |
| Pfizer | 46 | $780 |
| UCB, Inc. | 29 | $771 |
| Sanofi | 46 | $741 |
| Almirall LLC | 7 | $338 |
| LEO Pharma Inc. | 18 | $304 |
| Regeneron Healthcare Solutions, Inc. | 14 | $284 |
| Galderma Laboratories, L.p. | 9 | $252 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 13 | $230 |
| Mayne Pharma Commercial LLC | 11 | $182 |
| E.r. Squibb & Sons, L.L.C. | 9 | $147 |
| VYNE Pharmaceuticals Inc. | 2 | $122 |
| Janssen Scientific Affairs, LLC | 3 | $88 |
| Boehringer Ingelheim | 3 | $73 |
| Dermavant Sciences, Inc. | 3 | $61 |
| Dermira, Inc. | 2 | $41 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| Merck | 2 | $33 |
| Merz North America, Inc. | 1 | $30 |
| Prugen, Inc. Pharmaceuticals | 2 | $29 |
| Aclaris Therapeutics, Inc. | 2 | $29 |
| Journey Medical Corporation | 1 | $26 |
| Bristol Myers Squibb | 1 | $25 |
| Biofrontera Inc. | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
| Mission Pharmacal Company | 1 | $11 |
| Sanofi-aventis U.S. LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few dermatopathology providers in Indianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 25 | $100,099 |
| Clobetasol Propionate | 88 | $4,191 |
| Fluorouracil | 26 | $1,972 |
| Ketoconazole | 159 | $1,853 |
| Metronidazole | 34 | $1,770 |
| Calcipotriene | 14 | $1,539 |
| Doxycycline Hyclate | 72 | $1,463 |
| Clindamycin Phosphate | 48 | $1,151 |
| Fluocinonide | 35 | $1,128 |
| Ammonium Lactate | 39 | $977 |
| Triamcinolone Acetonide | 120 | $820 |
| Tretinoin | 12 | $513 |
| Hydrocortisone | 96 | $485 |
| Cephalexin | 56 | $480 |
| Acyclovir | 22 | $393 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Indianapolis
- Judy HamadIndianapolis$641
- Emily KellerGreenwood$91K
- Claudia VidalBloomington$4K
- Larry BuckelGreenwood$370
- Gary DillonLafayette$141
- Hany OsmanFort Wayne$15
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.